Lv21
128 积分 2021-02-18 加入
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
9天前
已完结
Resetting autoimmune disease with CAR cell therapies
13天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
14天前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
22天前
已完结
Efficacy and Safety of MIL62, a Glycoengineered Type II Anti-CD20 Antibody, in Primary Membranous Nephropathy: A Phase 3, Randomized, Controlled Trial
26天前
已完结
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
27天前
已完结
Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
1个月前
已完结
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial
1个月前
已完结
Targeting B Cells and Plasma Cells in Glomerular Disease
1个月前
已完结
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
